Evaluating speech therapy for Primary Progressive Aphasia

Communication Bridge: Optimizing an Evidence-based Intervention for Individuals With Primary Progressive Aphasia

Phase 2 Interventional University of Chicago · NCT06191198

This study is testing if speech therapy and a special app can help adults with mild to moderate Primary Progressive Aphasia communicate better.

Quick facts

PhasePhase 2
Study typeInterventional
Enrollment200 (estimated)
Ages18 Years to 100 Years
SexAll
SponsorUniversity of Chicago Academic / other
Locations1 site (Chicago, Illinois)
Trial IDNCT06191198 on ClinicalTrials.gov

What this trial studies

This study evaluates the effects of two evidence-based treatments for adults with mild to moderate Primary Progressive Aphasia (PPA) through a randomized controlled trial design. Participants will engage in up to 20 speech therapy sessions with a licensed therapist and utilize a personalized web application called Communication Bridge to practice at home. The study aims to enhance communication abilities in individuals with PPA and involves both the participants and their care partners over a period of approximately 17 months. There are no costs associated with participation.

Who should consider this trial

Good fit: Ideal candidates include adults diagnosed with mild to moderate Primary Progressive Aphasia who are English speakers and have adequate hearing and vision.

Not a fit: Patients with severe PPA or those who do not meet the eligibility criteria may not benefit from this study.

Why it matters

Potential benefit: If successful, this study could significantly improve communication abilities for patients with Primary Progressive Aphasia.

How similar studies have performed: Other studies have shown promising results with similar speech therapy approaches for aphasia, indicating potential for success in this trial.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria (person with PPA):

1. Meets diagnostic criteria for PPA based on neurologist and supporting medical assessments (extracted from medical records)
2. English as primary language used in daily communication activities (by self-report)
3. Adequate hearing (aided or unaided) for communicating with others in a crowded room (by self-report)
4. Adequate vision (aided or unaided) for reading a newspaper, or other functional materials (by self-report)
5. Able to pass technology screening and demonstrates sufficient knowledge for use of video conference and Communication Bridge™ web application use (with or without training)
6. Geriatric Depression Scale score ≤ 9
7. Mild-moderate PPA informed by a structured interview with a speech-language pathologist and a standardized testing battery.

Inclusion Criteria (Co-enrolled communication partner):

1. 18+ years of age
2. English as primary language used in daily communication activities (by self-report)
3. Adequate hearing (aided or unaided) for communicating with others in a crowded room (by self-report)
4. Able to pass technology screening\* and demonstrates sufficient knowledge for use of video conference and Communication Bridge™ web application use (with or without training)

Exclusion Criteria:

* A dementia diagnosis other than Primary Progressive Aphasia
* Participation is co-enrolled in an outside speech language therapy program during the study course.
* Communication partners will be excluded if they have a pre-existing communication impairment that would affect study participation (e.g., aphasia, dementia)

Medical records will be requested and reviewed to determine eligibility

Where this trial is running

Chicago, Illinois

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Primary Progressive AphasiaAphasiaDementiaCommunicationFrontotemporal DementiaAlzheimer Disease
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.